BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10738224)

  • 1. Human tumor growth is inhibited by a vaccinia virus carrying the E2 gene of bovine papillomavirus.
    Valdez Graham V; Sutter G; José MV; García-Carranca A; Erfle V; Moreno Mendoza N; Merchant H; Rosales R
    Cancer; 2000 Apr; 88(7):1650-62. PubMed ID: 10738224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant vaccinia virus containing the papilloma E2 protein promotes tumor regression by stimulating macrophage antibody-dependent cytotoxicity.
    Rosales C; Graham VV; Rosas GA; Merchant H; Rosales R
    Cancer Immunol Immunother; 2000 Sep; 49(7):347-60. PubMed ID: 10999461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma: a phase I/II study.
    Albarran Y Carvajal A; de la Garza A; Cruz Quiroz BJ; Vazquez Zea E; Díaz Estrada I; Mendez Fuentez E; López Contreras M; Andrade-Manzano A; Padilla S; Varela AR; Rosales R
    BioDrugs; 2007; 21(1):47-59. PubMed ID: 17263589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonreplicating vaccinia vector efficiently expresses recombinant genes.
    Sutter G; Moss B
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10847-51. PubMed ID: 1438287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.
    Hornemann S; Harlin O; Staib C; Kisling S; Erfle V; Kaspers B; Häcker G; Sutter G
    J Virol; 2003 Aug; 77(15):8394-407. PubMed ID: 12857909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase.
    Sutter G; Ohlmann M; Erfle V
    FEBS Lett; 1995 Aug; 371(1):9-12. PubMed ID: 7664891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line.
    Carroll MW; Moss B
    Virology; 1997 Nov; 238(2):198-211. PubMed ID: 9400593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early gene expression of vaccinia virus strains replicating (Praha) and non-replicating (modified vaccinia virus strain Ankara, MVA) in mammalian cells.
    Nemecková S; Hainz P; Otáhal P; Gabriel P; Sroller V; Kutinová L
    Acta Virol; 2001; 45(4):243-7. PubMed ID: 11885931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of human papillomavirus intraepithelial lesions is induced by MVA E2 therapeutic vaccine.
    Rosales R; López-Contreras M; Rosales C; Magallanes-Molina JR; Gonzalez-Vergara R; Arroyo-Cazarez JM; Ricardez-Arenas A; Del Follo-Valencia A; Padilla-Arriaga S; Guerrero MV; Pirez MA; Arellano-Fiore C; Villarreal F
    Hum Gene Ther; 2014 Dec; 25(12):1035-49. PubMed ID: 25275724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells.
    Zwilling J; Sliva K; Schwantes A; Schnierle B; Sutter G
    Virology; 2010 Sep; 404(2):231-9. PubMed ID: 20627347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells.
    Erez N; Wyatt LS; Americo JL; Xiao W; Moss B
    J Virol; 2021 Sep; 95(19):e0110421. PubMed ID: 34232734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes.
    Ludwig H; Mages J; Staib C; Lehmann MH; Lang R; Sutter G
    J Virol; 2005 Feb; 79(4):2584-96. PubMed ID: 15681458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation.
    Shisler JL; Jin XL
    J Virol; 2004 Apr; 78(7):3553-60. PubMed ID: 15016878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified vaccinia virus Ankara as a vector for suicide gene therapy.
    Erbs P; Findeli A; Kintz J; Cordier P; Hoffmann C; Geist M; Balloul JM
    Cancer Gene Ther; 2008 Jan; 15(1):18-28. PubMed ID: 17992203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of intratumoral injections of vaccinia virus MVA expressing GM-CSF and immunization with DNA vaccine prolongs the survival of mice bearing HPV16 induced tumors with downregulated expression of MHC class I molecules.
    Nemeckova S; Smahel M; Hainz P; Mackova J; Zurkova K; Gabriel P; Indrova M; Kutinova L
    Neoplasma; 2007; 54(4):326-33. PubMed ID: 17822323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells.
    Peng C; Moss B
    Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3759-3767. PubMed ID: 32019881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
    Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
    Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectors.
    Zhang X; Cassis-Ghavami F; Eller M; Currier J; Slike BM; Chen X; Tartaglia J; Marovich M; Spearman P
    J Virol; 2007 Jul; 81(13):7022-33. PubMed ID: 17409140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression.
    Marín MQ; Pérez P; Gómez CE; Sorzano CÓS; Esteban M; García-Arriaza J
    Viruses; 2018 Aug; 10(8):. PubMed ID: 30096846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.